Roche Acquires Exclusive Licence for Clinical Phase Cancer Vaccine

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 83 (Table of Contents)

Published: 7 May-2007

DOI: 10.3833/pdr.v2007.i83.348     ISSN: 1756-7874

Section: Licensing



Transgene and Roche entered into license agreement for Transgene’s TG400 I, which is in phase 2 clinical trials for treating anti-HPV cancer vaccine...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details